
Dendritic cells (DCs) orchestrate immune responses, and metabolic processes act as key checkpoints underlying their function. In this Review, we summarize how metabolism shapes DC biology, including in different disease settings. We first discuss the effects of metabolic programmes on the immunogenic and tolerogenic functions of DCs. Then, we discuss the roles of extracellular nutrients and metabolites in orchestrating intracellular signalling in DCs, as well as their effects on the bidirectional metabolic interactions between DCs and the local tissue microenvironment. Additionally, we describe how metabolism governs DC function in the settings of cancer, autoimmunity and metabolic disorders and conclude with a discussion on key future directions for the field. Understanding the metabolic processes that dictate DC function holds strong translational potential for the treatment of immune-mediated diseases. This Review explores how nutrients, metabolites and metabolic programmes shape the immunogenic and tolerogenic functions of dendritic cells (DCs). The authors summarize how DC metabolism affects their functions in various disease settings, including cancer and autoimmunity, and discuss emerging therapies that involve targeting DC metabolism.
Red meat has long been associated with inflammatory disease. New research identifies l-carnitine as a potential molecular link between diet and inflammation.
A preprint by Schoenfeld et al. investigates the relationship between iron restriction and the function of tumour-infiltrating lymphocytes in pancreatic ductal adenocarcinoma.
Large-scale autoantibody profiling reveals pathogenic anti-IL-1RA autoantibodies that disrupt placental vascular integrity and are associated with preterm birth, linking maternal humoral immunity to inflammatory pregnancy complications.
A preprint by Nah et al. reports that PD-L1 and PD-L2 on dendritic cells in the tumour versus tumour-draining lymph nodes have spatially regulated effects on the antitumour T cell response.